A simultaneous modification of A agglutinogen of erythrocytes and loss of specific platelet antigens in a patient with gall bladder carcinoma.
D000372:Agglutination Tests; D000941:Antigens / Q000032:analysis*; D001789:Blood Group Antigens; D001792:Blood Platelets / Q000032:analysis / Q000187:drug effects / Q000276:immunology*; D004912:Erythrocytes / Q000032:analysis / Q000187:drug effects / Q000276:immunology*; D005260:Female; D005706:Gallbladder Neoplasms / Q000276:immunology*; D006386:Hemagglutination Tests; D006801:Humans; D008113:Liver Neoplasms; D015122:Mercaptopurine / Q000494:pharmacology; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011241:Prednisone / Q000494:pharmacology
D000941:Antigens; D001789:Blood Group Antigens; D015122:Mercaptopurine; D011241:Prednisone